An update on the anti-Spike monoclonal antibody pipeline for SARS-CoV-2

D Focosi, M Franchini, A Casadevall, F Maggi - Clinical Microbiology and …, 2024 - Elsevier
Abstract Background Anti-Spike monoclonal antibodies represent one of the most tolerable
prophylaxis and therapies for COVID-19 in frail and immunocompromised patients …

From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2

A Kumar, P Tripathi, P Kumar, R Shekhar, R Pathak - Vaccines, 2024 - mdpi.com
Understanding the antibody response to SARS-CoV-2, the virus responsible for COVID-19,
is crucial to comprehending disease progression and the significance of vaccine and …

8 Antibodies in COVID-19

MZ Khan, R Leeson, C Henry… - The COVID-19 Textbook …, 2023 - books.google.com
8 Antibodies in COVID-19 Page 418 CHAPTER 8 Antibodies in COVID-19 Mehak Zahoor Khan •
Rachel Leeson • Carole Henry • Galit Alter Introduction Antibodies Fc-Receptors Antibody …

Molecular characterization of AZD7442 (tixagevimab-cilgavimab) neutralization of SARS-CoV-2 Omicron subvariants

TL Roe, T Brady, N Schuko, A Nguyen… - Microbiology …, 2023 - Am Soc Microbiol
Therapeutic anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
monoclonal antibodies (MAbs) provide immunosuppressed and vulnerable populations with …